Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease

NCT02074410 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

22

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision - pending further analysis of available data

Conditions

Huntington's Disease

Interventions

DRUG: OMS643762
DRUG: Placebo

Sponsor

Omeros Corporation